Researchers have developed a peptide that targets a previously ‘undruggable’ protein implicated in more than 75% of human cancers and found that it slowed the proliferation of brain cancer cells in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback